We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The dPCR assay targets the most common KMT2A partner fusion genes found in AML and ALL, aligning with the disease biology relevant to current menin inhibitor programs (Image Credit: Shutterstock)

Global Testing Service Advances Leukemia MRD Monitoring

A new digital PCR test measures residual disease markers in acute leukemias with high sensitivity. More...
06 Aug 2026
Image: Medicare coverage for NeXT Personal now spans four indications (Photo courtesy of Personalis)

Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

Personalis’ NeXT Personal received expanded Medicare coverage for immuno-oncology and neoadjuvant breast cancer monitoring. More...
06 Aug 2026
Image: Data from thousands of blood samples allowed the researchers to compare different biological processes involved in multiple sclerosis. (Photo courtesy of Kathleen Herrgott, RC2NB)

Blood Biomarker Reveals Hidden Disability Progression in Multiple Sclerosis

New findings show that a blood marker tracks relapse-independent MS progression and signals treatment response. More...
06 Aug 2026
Image: The dPCR assay targets the most common KMT2A partner fusion genes found in AML and ALL, aligning with the disease biology relevant to current menin inhibitor programs (Image Credit: Shutterstock)

Global Testing Service Advances Leukemia MRD Monitoring

A new digital PCR test measures residual disease markers in acute leukemias with high sensitivity. More...
05 Aug 2026
Image: Medicare coverage for NeXT Personal now spans four indications (Photo courtesy of Personalis)

Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

Personalis’ NeXT Personal received expanded Medicare coverage for immuno-oncology and neoadjuvant breast cancer monitoring. More...
05 Aug 2026
Image Credit: Shutterstock

Single Liquid Biopsy Predicts Early Immunotherapy Benefit in Advanced Lung Cancer

A new single-time-point ctDNA liquid biopsy predicts NSCLC immunotherapy benefit within weeks. More...
05 Aug 2026
Image: Benchmarking design for systematic evaluation of PASEF acquisition strategies (Xian, F., Mitulovic, G., Ravi Kumar, R.K. et al.  Nature Communications. https://doi.org/10.1038/s41467-026-75845-5)

Proteomic Workflow Maps Microbial and Host Responses in Intestinal Inflammation

New data show that advanced protein profiling reliably maps active microbial and patient responses in intestinal inflammation. More...
05 Aug 2026
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
HPV Test
Allplex HPV28 Detection